Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(3.92)
# 629
Out of 5,182 analysts
336
Total ratings
41.16%
Success rate
13.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $51.22 | +56.19% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $67.82 | +10.59% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $75.17 | -13.53% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $23.05 | -39.26% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $12.68 | +688.64% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $59.58 | -24.47% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $18.16 | +313.00% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $35.26 | -14.92% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $19.67 | +123.69% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $21.18 | -52.79% | 16 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $22.39 | -55.34% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $13.49 | +122.39% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $8.11 | +1,441.31% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $13.66 | +9.81% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.13 | +342.48% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $8.95 | -44.13% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.39 | +13.90% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $5.98 | +150.84% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $20.34 | +121.29% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.94 | +2.04% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $5.98 | +568.90% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.37 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.38 | +407.25% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $5.65 | -46.90% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $2.25 | -11.11% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.74 | +1,116.22% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.91 | +205.50% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36,160,000 → $13,786,000 | $0.50 | +2,746,215,039.44% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.30 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $51.22
Upside: +56.19%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $67.82
Upside: +10.59%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $75.17
Upside: -13.53%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $23.05
Upside: -39.26%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $12.68
Upside: +688.64%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $59.58
Upside: -24.47%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $18.16
Upside: +313.00%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $35.26
Upside: -14.92%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $19.67
Upside: +123.69%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $21.18
Upside: -52.79%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $22.39
Upside: -55.34%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $13.49
Upside: +122.39%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $8.11
Upside: +1,441.31%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $13.66
Upside: +9.81%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.13
Upside: +342.48%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $8.95
Upside: -44.13%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $4.39
Upside: +13.90%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $5.98
Upside: +150.84%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $20.34
Upside: +121.29%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.94
Upside: +2.04%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $5.98
Upside: +568.90%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.37
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.38
Upside: +407.25%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $5.65
Upside: -46.90%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $2.25
Upside: -11.11%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.74
Upside: +1,116.22%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $4.91
Upside: +205.50%
Sep 6, 2023
Maintains: Buy
Price Target: $36,160,000 → $13,786,000
Current: $0.50
Upside: +2,746,215,039.44%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $2.30
Upside: -